This inventor holds 1 USPTO granted patent. Top assignees: National Cancer Center, Transgenic Inc.. Active years: 2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 264 
1 out of 8 Years Active: 2017
Title: Kazunari Ito: Innovator in Antibody Development
Introduction
Kazunari Ito is a notable inventor based in Kobe, Japan. He has made significant contributions to the field of biotechnology, particularly in the development of antibodies. His work has implications for various medical applications, especially in cancer research.
Latest Patents
Kazunari Ito holds a patent for an antibody against mutant α-actinin-4. This antibody is designed to recognize an amino acid sequence with at least one substitution in the region between positions 245 and 263 of α-actinin-4. The innovation lies in its ability to target the substituted amino acid residues, which can be crucial for therapeutic interventions.
Career Highlights
Throughout his career, Kazunari Ito has worked with prominent organizations such as Transgenic Inc. and the National Cancer Center. His experience in these institutions has allowed him to advance his research and contribute to the scientific community.
Collaborations
Kazunari has collaborated with esteemed colleagues, including Yoshimi Tokashiki and Kazufumi Honda. These partnerships have fostered a collaborative environment that enhances the quality and impact of their research.
Conclusion
Kazunari Ito's work in antibody development showcases his innovative spirit and dedication to advancing medical science. His contributions are vital for future research and therapeutic applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile